Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries

Malvina Hoxha, Elira Tashi, Brunilda Elezi, Hedie Haxhiu

Open source

DOI
10.1080/14737167.2026.2737547
Published
2026-09-23
Container
Expert Review of Pharmacoeconomics & Outcomes Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737167.2026.2737547,
  title = {Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries},
  author = {Malvina Hoxha and Elira Tashi and Brunilda Elezi and Hedie Haxhiu},
  year = {2026},
  journal = {Expert Review of Pharmacoeconomics \& Outcomes Research},
  doi = {10.1080/14737167.2026.2737547},
  url = {https://doi.org/10.1080/14737167.2026.2737547}
}

RIS

TY  - JOUR
TI  - Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries
AU  - Malvina Hoxha
AU  - Elira Tashi
AU  - Brunilda Elezi
AU  - Hedie Haxhiu
PY  - 2026
JO  - Expert Review of Pharmacoeconomics & Outcomes Research
DO  - 10.1080/14737167.2026.2737547
UR  - https://doi.org/10.1080/14737167.2026.2737547
ER  - 

APA

Hoxha, M., Tashi, E., Elezi, B., & Haxhiu, H. (2026). Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2026.2737547

Source records